Skip to content
drillr.ai
Sign up

600529.SH

Shandong Pharmaceutical Glass Co., Ltd.

SSE · Consumer Cyclical · Packaging & Containers · CN

CNY 17.86
−0.61%
Ask drillr

  • Oct 26, 2026, 10:07 UTC

    Shandong Pharmaceutical Glass reported first-nine-month 2026 revenue of 3.249 billion yuan, down 3.07% year over year, and net profit of 520 million yuan, down 4.09%.

    Source:

  • Oct 26, 2026, 10:07 UTC

    Shandong Pharmaceutical Glass reported third-quarter 2026 revenue of 969 million yuan, down 12.07% year over year, and net profit of 149 million yuan, down 12.79%.

    Source:

  • Oct 26, 2026, 10:06 UTC

    Shandong Pharmaceutical Glass said its board approved the company's third-quarter 2026 report.

    Source:

  • Oct 26, 2026, 10:06 UTC

    Shandong Pharmaceutical Glass said its board approved an increase in its estimated daily related-party transactions for 2026.

    Source:

  • Oct 26, 2026, 10:06 UTC

    Shandong Pharmaceutical Glass said it signed Supplementary Agreement (III) to the conditional share subscription agreement with the offering investors, and that the offering constitutes a related-party transaction.

    Source:

  • Oct 26, 2026, 10:06 UTC

    Shandong Pharmaceutical Glass said its board approved revisions to the lock-up arrangements for its 2026 A-share offering to specific investors and updated the offering plan and prospectus.

    Source:

  • Oct 8, 2026, 09:07 UTC

    Shandong Pharmaceutical Glass said it responded to the Shanghai Stock Exchange’s review inquiry on its proposed private placement of A-shares and updated its application documents, which were disclosed the same day.

    Source:

  • Sep 18, 2026, 07:40 UTC

    Shanghai Stock Exchange issued a review inquiry letter to Shandong Pharmaceutical Glass regarding its application for a targeted private placement of shares.

    Source:

  • Sep 17, 2026, 08:20 UTC

    Shandong Pharmaceutical Glass's application to issue A-shares to specific investors was accepted by the Shanghai Stock Exchange for review.

    Source:

  • Aug 24, 2026, 08:46 UTC

    Shandong Pharmaceutical Glass disclosed its semi-annual report on August 24, reporting revenue of 2.28 billion yuan (up 1.34% year-on-year) and net profit attributable to shareholders of 371 million yuan (down 0.07% year-on-year).

    Source:

  • Aug 24, 2026, 08:46 UTC

    Shandong Pharmaceutical Glass proposed a cash dividend of 3 yuan (pre-tax) per 10 shares to all shareholders.

    Source: